Blumenthal, EZ;
Cordeiro, MF;
Shmetterer, L;
Verbin, HL;
Harris, A;
(2019)
ISOPT Clinical Hot Topic Panel Discussion on Glaucoma.
Journal of Ocular Pharmacology and Therapeutics
, 35
(8)
pp. 441-446.
10.1089/jop.2019.0004.
Preview |
Text
Cordeiro Glaucoma Hot Topics- ISOPT 2018- Version 5.pdf - Accepted Version Download (179kB) | Preview |
Abstract
As part of the 14th International Symposium on Ocular and Pharmacological Therapeutics, a unique panel was gathered to discuss two cardinal questions related to the treatment of glaucoma, peeking into the future: (1) What shape and form will glaucoma medical treatment have five and fifteen years from today, and (2) Will personalized medicine be commonly used five years from now. For each of the questions, we assigned an “optimist” and “pessimist” who provided the assigned point of view, for a total of 4 discussants, the authors of this panel discussion.
| Type: | Article |
|---|---|
| Title: | ISOPT Clinical Hot Topic Panel Discussion on Glaucoma |
| Location: | Tel Aviv, ISRAEL |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1089/jop.2019.0004 |
| Publisher version: | https://doi.org/10.1089/jop.2019.0004 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Ophthalmology, Pharmacology & Pharmacy, glaucoma, progression, medical treatment, personalized medicine |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10085933 |
Archive Staff Only
 |
View Item |
